Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis

Introduction Metabolic dysfunction-associated steatohepatitis (MASH) is highly prevalent in type 2 diabetes (T2D). Pioglitazone and glucagon-like peptide-1 receptor agonists (GLP-1RA) are medications used in T2D that can resolve MASH and should be considered in all patients with T2D and MASH. We ass...

全面介紹

書目詳細資料

Principais autores:	Anastasia-Stefania Alexopoulos, Matthew J Crowley, Alice Parish, Maren Olsen, Bryan C Batch, Cynthia Moylan
格式:	Artigo
語言:	Inglês
出版:	BMJ Publishing Group 2023-11-01
叢編:	BMJ Open Diabetes Research & Care
在線閱讀:	https://drc.bmj.com/content/11/6/e003763.full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!